BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G951. A total of 6 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,636 | -39.4% | 41,100 | -40.6% | 0.00% | -40.0% |
| Q2 2023 | $5,998 | +25.4% | 69,200 | +40.7% | 0.01% | +25.0% |
| Q1 2023 | $4,784 | -38.8% | 49,200 | -34.8% | 0.00% | -50.0% |
| Q4 2022 | $7,813 | -99.9% | 75,500 | +16.2% | 0.01% | +33.3% |
| Q3 2022 | $5,510,000 | +18.8% | 65,000 | +16.1% | 0.01% | +20.0% |
| Q2 2022 | $4,640,000 | +195.2% | 56,000 | +174.5% | 0.01% | +400.0% |
| Q1 2022 | $1,572,000 | -67.0% | 20,400 | -62.2% | 0.00% | -80.0% |
| Q4 2021 | $4,762,000 | -39.9% | 53,900 | -43.0% | 0.01% | -28.6% |
| Q3 2021 | $7,929,000 | +0.6% | 94,500 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $7,885,000 | +26.3% | 94,500 | +11326.8% | 0.01% | -27.3% |
| Q1 2021 | $6,244,000 | +10.9% | 827 | +28.8% | 0.01% | +57.1% |
| Q4 2020 | $5,629,000 | -8.2% | 642 | -20.3% | 0.01% | -12.5% |
| Q3 2020 | $6,132,000 | -32.0% | 806 | +10.3% | 0.01% | -42.9% |
| Q2 2020 | $9,016,000 | +53.1% | 731 | +4.9% | 0.01% | +40.0% |
| Q1 2020 | $5,889,000 | +48.5% | 697 | +48.6% | 0.01% | +11.1% |
| Q4 2019 | $3,965,000 | +265.4% | 469 | +191.3% | 0.01% | +200.0% |
| Q3 2019 | $1,085,000 | -53.9% | 161 | -41.5% | 0.00% | -50.0% |
| Q2 2019 | $2,355,000 | -38.2% | 275 | -35.9% | 0.01% | -45.5% |
| Q1 2019 | $3,810,000 | +134.3% | 429 | +124.6% | 0.01% | +120.0% |
| Q4 2018 | $1,626,000 | -42.0% | 191 | -33.9% | 0.01% | -44.4% |
| Q3 2018 | $2,802,000 | +2.9% | 289 | 0.0% | 0.01% | -18.2% |
| Q2 2018 | $2,722,000 | +5344.0% | 289 | +191.9% | 0.01% | +450.0% |
| Q1 2018 | $50,000 | -36.7% | 99 | -77.7% | 0.00% | -33.3% |
| Q4 2017 | $79,000 | +146.9% | 443 | +119.3% | 0.00% | +200.0% |
| Q3 2017 | $32,000 | -65.2% | 202 | -15.8% | 0.00% | -75.0% |
| Q2 2017 | $92,000 | +135.9% | 240 | +43.7% | 0.00% | +100.0% |
| Q1 2017 | $39,000 | -82.7% | 167 | -58.7% | 0.00% | -84.6% |
| Q4 2016 | $225,000 | +112.3% | 404 | +18.8% | 0.01% | +85.7% |
| Q3 2016 | $106,000 | -64.4% | 340 | +30.8% | 0.01% | -65.0% |
| Q2 2016 | $298,000 | +75.3% | 260 | +114.9% | 0.02% | +42.9% |
| Q1 2016 | $170,000 | +246.9% | 121 | -1.6% | 0.01% | +250.0% |
| Q4 2015 | $49,000 | -85.0% | 123 | -8.2% | 0.00% | -83.3% |
| Q3 2015 | $326,000 | +462.1% | 134 | +0.8% | 0.02% | +380.0% |
| Q2 2015 | $58,000 | +114.8% | 133 | +51.1% | 0.01% | +66.7% |
| Q1 2015 | $27,000 | +1250.0% | 88 | +83.3% | 0.00% | – |
| Q4 2014 | $2,000 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 35,000 | $3,403,400 | 0.01% |
| SIMPLEX TRADING, LLC | 49,200 | $4,784 | 0.00% |
| JANE STREET GROUP, LLC | 58,200 | $5,659,368 | 0.00% |
| JPMORGAN CHASE & CO | 26,300 | $2,557,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |